Should Gynecologic Cancer Patients Consider Clinical Trials
Links shared publicly online about this topic
Gynecologic Cancer Patients Should Consider Clinical Trials
medicalnewstoday.com — “For the estimated 83,000 women who will be diagnosed with a gynecologic cancer in 2010, participation in clinical trials offers an opportunity both to ensure that future patients benefit from the” View full resource at medicalnewstoday.com
Most Recently Shared on September 6, 2010 at 12:37 pm By:
Women's Health Line Health Site
Gynecologic Cancer Patients Should Consider Clinical Trials http://sns.ly/xSL49 #womenshealth
Health News - Gynecologic Cancer Patients Should Consider Clinical Trials
healthcanal.com — “Gynecologic Cancer Patients Should Consider Clinical Trials” View full resource at healthcanal.com
Most Recently Shared on September 7, 2010 at 12:00 pm By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Gynecologic Cancer Patients Should Consider Clinical Trials http://ow.ly/2AhG9
American Ginseng in Treating Patients With Fatigue Caused by Cancer - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “American Ginseng in Treating Patients With Fatigue Caused by Cancer - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on November 18, 2009 at 6:46 pm By:
Research loving Paul Allen should consider this clinical trial at the Hutch in Seattle! http://bit.ly/1P3Qxe
Noninvasive, Effective Treatment For Frail Patients With Early-Stage Lung Cancer Offered By Stereotactic Radiotherapy
medicalnewstoday.com — “Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results fro” View full resource at medicalnewstoday.com
Most Recently Shared on November 3, 2009 at 3:41 pm By:
MNT Clinical Trials Health News
Noninvasive, Effective Treatment For Frail Patients With Early-Stage Lung Cancer Offered By Stereotactic Radiot.. http://bit.ly/sVkd9
Medical News: ASCO Breast: Ten Years On, Anastrazole Still Tops SERM - in Meeting Coverage, ASCO Breast from MedPage Today
medpagetoday.com — “NATIONAL HARBOR, Md. -- The aromatase inhibitor anastrozole (Arimidex) extended its disease control advantage over tamoxifen in an analysis of 10-year outcomes in a large randomized clinical trial in” View full resource at medpagetoday.com
Most Recently Shared on October 4, 2010 at 12:20 am By:
ASCO Breast: Ten Years On, Anastrazole Still Tops SERM http://bit.ly/cJynSK
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Women's Health Line
The latest women's health news and research.
-
JanCerny, MD, PhD
Assistant Professor, UMASS, HemOnc, BMT, Lymphoma, Leukemia
-
Lymphomation.org
Lymphomation.org/Patients Against Lymphoma -- Providing support and timely access to evidence-based information on lymphomas and their treatment.
Advertisement
